BSEBoard Meeting3d ago · 6 Nov 2026, 08:35 pm
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Dolphin Medical Services Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the Unaudited Financial Result of the company for the quarter & half year ended 30 September, 2026.
Dolphin Medical Services Ltd · 526504
✦ AI SummaryResults
Dolphin Medical Services Ltd has scheduled a Board Meeting on November 14, 2026, to consider and approve the Unaudited Financial Results for the second quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dolphin Medical Services Ltd - 526504 - Board Meeting Intimation for Board Meeting Intimation For Intimation Of Board Meeting Of Dolphin Medical Services Ltd Scheduled On November 14, 2026.
Attachments (1)
📄pdf
Download →
0256079c-4966-4c0f-99c6-2591dee89dc9.pdf
View document text
To, Dated: 06th November, 2026
BSE Limited
Department of Corporate Services
P. J. Tower, Dalal Street,
Mumbai - 400 020, Maharashtra, India.
SCRIP CODE: 526504
Subject: Intimation of Board Meeting of DOLPHIN MEDICAL SERVICES LTD (“The
Company”).
Ref: Regulation 29(1) of Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
Pursuant to Regulation 29(1) of the SEBI Listing Regulations, this is to inform that a meeting
of the Board of Directors of the Company is scheduled to be held on Saturday, November 14,
2026, inter alia, to consider & approve the Unaudited Standalone Financial Results for the
Second quarter & half year ended September 30, 2026 and other matters of the Company.
Further, in continuation to our earlier intimation, in compliance with the provisions of the
Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015,
and the Company’s “Code of Internal Procedures and Conduct for Regulating, Monitoring and
Reporting of Trading in Securities by Insiders”, the Trading Window for dealing in the
securities of the Company for all the Designated Persons, including Insiders, had already been
closed with effect from October 01, 2026, and will remain closed till 48 hours after the
publication of the financial results.
You are requested to take the above information on record.
. Thanking you,
For DOLPHIN MEDICAL SERVICES LTD
Rajesh Kumar Mallour
Director
DIN: 08125774
DOLPHIN MEDICAL SERVICES LIMITED
CIN: L24239TG1992PLC014775
Registered Office: Level 3, Plot No 13, Greenlands Colony, Besides Flyover Gachibowli, Hyderabad– 500032
Email: dolphinmedicalindia@gmail.com; Ph No : +91 7981598498